Last edition
News about Drug Discovery & Development
Merz Therapeutics and Kvvit Sign China Deal for INBRIJA Parkinson's Therapy
Merz Therapeutics and Kvvit sign an exclusive agreement for commercialization of INBRIJA in mainland China, Hong Kong, and Macao, expanding access to advanced treatment options for Parkinson's disease patients.
Drug Discovery & Development | 26/05/2026 | By News Bureau | 232
Ichnos Glenmark Innovation Unveils Novel Multispecific Antibody Candidate for Solid Tumour Treatment
Ichnos Glenmark Innovation has introduced ISB 2301, a next-generation multispecific antibody designed to activate immune cells and target solid tumours through a multi-mechanism approach aimed at improving cancer treatment outcomes.
Drug Discovery & Development | 22/05/2026 | By News Bureau | 260
RFiD Discovery Deploys RFID Inventory Tracking System for Sanofi R&D Sites
RFiD Discovery has implemented a passive RFID inventory management system for Sanofi, enabling real-time tracking of critical research materials at its R&D facilities in France and the United States.
Drug Discovery & Development | 18/05/2026 | By News Bureau | 165
Researchers Discover First Human Antibody Panel Targeting Measles Virus
NIH-funded researchers identify the first suite of human antibodies targeting the measles virus, paving the way for new antibody-based treatments.
Drug Discovery & Development | 16/05/2026 | By News Bureau | 181
VoxCell BioInnovation and adMare BioInnovations have launched a research partnership focused on validating antibody-based cancer therapies using advanced bioprinted human tissue models designed to improve predictive drug testing and accelerate oncology innovation.
Drug Discovery & Development | 15/05/2026 | By News Bureau | 150
Fosun Pharma and AriBio Sign Global Deal for AR1001 to Treat Alzheimer's
Fosun Pharma and AriBio signed an exclusive global option agreement for AR1001, an investigational Alzheimer’s disease treatment, with a USD 60 million option fee.
Drug Discovery & Development | 14/05/2026 | By News Bureau | 466
Scientists at The University of Tulsa have developed new memantine-based compounds capable of crossing the blood-brain barrier and demonstrating higher anticancer activity against glioblastoma cells than standard chemotherapy treatments.
Drug Discovery & Development | 12/05/2026 | By News Bureau | 139
Formosa Pharmaceuticals Partners with Singapore Eye Research Institute for Corneal Disease Therapies
Formosa Pharmaceuticals partners with Singapore Eye Research Institute to develop next-generation ophthalmic formulations using APNT nanoparticle technology and advanced clinical research expertise for corneal diseases.
Drug Discovery & Development | 02/05/2026 | By News Bureau | 184
A research team from Nagaland University has developed an eco-friendly method to convert the invasive plant Mikania micrantha into silver nanoparticles, boosting drug production, antibacterial activity, and promising cancer research without toxic chemicals.
Drug Discovery & Development | 22/04/2026 | By News Bureau | 146
Partner Therapeutics Submits sBLA to FDA for BIZENGRI
Partner Therapeutics submits sBLA to FDA for BIZENGRI in NRG1 fusion-positive cholangiocarcinoma, supported by eNRGy study data showing 36.8 percent response rate and durable efficacy.
Drug Discovery & Development | 15/04/2026 | By News Bureau | 187
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy